Suven Pharma Acquires Majority Stake in US-Based NJ Bio for $64.4 Million
Hyderabad-based Suven Pharmaceuticals has entered into definitive agreements to acquire a 56% equity stake in NJ Bio, Inc., a Contract Research, Development, and Manufacturing Organization (CRDMO) headquartered in Princeton, New Jersey. The $64.4 million transaction comprises a mix of primary equity infusion and secondary share acquisition. Key Details of the Acquisition NJ Bio is a […]
Suven Pharma Acquires Majority Stake in US-Based NJ Bio for $64.4 Million Read More »









